The Deepwater Horizon oil spill in the Gulf of Mexico has been called one of the worst-ever environmental disasters — and may prove to be perhaps even bigger than the 1989 Exxon Valdez catastrophe. For more than a month, crews off the Louisiana shore have tried to… Read More
Melvin Pasternak, Ph.D., is an experienced market technician. He designed a course for TD Waterhouse titled "Winning in the Stock Market," which combined intensive technical and fundamental analysis to uncover how to profitably beat the market. Dr. Pasternak was a professor at the Mount Royal University in Calgary, Alberta, for more than 25 years. In 2006, after retiring, he published his book on candlestick charting, 21 Candlesticks Every Trader Should Know. Due to his trading expertise, he has been interviewed several times by CBC Radio-Canada and the Calgary Herald.
Analyst Articles
The medical device sector is still reeling from the healthcare reform bill. Slapped with a 3% tax increase effective January 2013, many medical device manufacturers and distributors such as Medtronics (NYSE: MDT) and Stryker (NYSE: SYK) fear future sales and earnings… Read More
Now may be the optimal time to trade the financial sector. During the week of April 16, shares of many financial companies fell, following news of fraud charges against The Goldman Sachs Group, Inc. (NYSE: GS). As a result, many financial… Read More
With Apple (Nasdaq: AAPL) going gangbusters and lifting many other tech firms with it, the S&P Global Technology Index Fund (NYSE: IXN) may be a great idea. IXN’s assets are weighted toward large-cap global tech companies. Other top holdings include Microsoft (Nasdaq: MSFT), IBM (NYSE: IBM)… Read More
You Could See +19% Gains With This Pharma ETF
March 29, 2010
The intensely debated health care legislation has become law. Traders now speculate on how the bill impacts the health care sector. Of the winners and losers, the pharmaceutical companies have come out near the top. Over several years, they will pay $90 billion to help offset the… Read More
Playing Pure Value for a +14.5% Pure Profit
March 15, 2010
Many traders have asked me the same question during my 40 years of trading. What is the key to being successful? Over the years, I have seen a lot of changes in the market, but one strategy has stood the test of time: seeking out attractively valued… Read More
Profit From Toyota’s Deceleration
February 1, 2010
Just when it seemed the auto industry was beginning to rebound, Toyota Motor Corp. (NYSE: TM) has gone into reverse. Toyota — the world’s number one selling auto manufacturer — recently recalled 2.3 million cars in the United States, due to faulty floor mats which trap accelerator… Read More
The year 2009 ended with the S&P 500 at a crucial technical juncture. The positive trading action of the first day of 2010 did much to resolve the uncertainty. The October 2007 high water mark for the benchmark… Read More
This Los Angeles-based company sells weight-management shakes, snacks, and nutritional supplements, but its diet aids reach well beyond Hollywood’s slimmest stars. One obvious target audience is the whopping 66.7% of Americans who are overweight. And as people in the United… Read More
Trading Corner: Drug Services Company Bounces off Important Support
December 10, 2009
With the weak economy, drug makers have been scaling back their drug development plans. The slowdown has trickled down to the so-called contract research organizations (CRO), which help pharmaceutical and biotechnology firms manage the necessary clinical trials for a drug to be licensed… Read More